Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maysama is a UK-based cosmeceutical company that specializes in high-performance skincare formulated with pharmaceutical-grade Green Rooibos extract. The company focuses on the intersection of dermatology and biotechnology, utilizing patented extraction processes to maximize antioxidant potency for anti-aging and skin repair. Their product line includes topical serums and LED light therapy devices designed to work synergistically to improve skin health and cellular function. Maysama targets common dermatological concerns such as oxidative stress, inflammation, and collagen degradation through science-backed formulations. The brand is recognized for its commitment to eco-conscious practices and evidence-based skincare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maysama.